Company news
Nexalis Therapeutics Limited news in 2023
Nexalis Therapeutics Limited's news releases, calls and decks from 2023, newest first.
Significant Milestone - Completion of IRX211 Phase 1 Trial
December 3, 2023
Sep23 Quarterly Activities Report
October 31, 2023
Sep23 Appendix 4C
October 31, 2023
Quarterly Activities Report
July 30, 2023
Quarterly Appendix 4C Cash Flow Report
July 30, 2023
First Cohort Complete for Phase 1, Pain Indication IRX211
June 14, 2023
First Patient Dosed for Phase 1, Pain Indication IRX211
June 7, 2023
Ethics Approval for Phase 1 CRPS
March 20, 2023
Decks in 2023
- InhaleRx — Investor Presentation (November 2023)
Investor deck · 17 slides · Nov 22, 2023